

HY-P9948 · 1 mg
MedChemExpress · Cat: HY-P9948
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/alemtuzumab.html
Description
Alemtuzumab Campath-IH is a humanized monoclonal antibody against CD52. Alemtuzumab does not cross-react with murine CD52. Alemtuzumab selectively targets the CD52 antigen to induce profound lymphocyte depletion, followed by recovery of T and B cells with regulatory phenotypes. Alemtuzumab is capable of complement-dependent cytotoxicity and antibody-dependent cell-mediated cytotoxicity ADCC , as well as induction of apoptosis. Alemtuzumab has the potential for B-cell chronic lymphocytic leukaemia research.







